Skip to main content
Latest news
Browse specialties
Breast cancer Genitourinary cancers Lung & thoracic cancers
In focus
Next-generation sequencing: Emerging biomarkers in thyroid and NSCLCs ctDNA and bladder cancer: Current understanding and beyond ROS1 fusion-positive NSCLC NSCLC driver mutations: Discussing the importance of RET, ALK and ROS1 alterations in NSCLC Early-stage NSCLC management: Surgery, targeted treatment and immunotherapy ALK fusion-positive NSCLC: International approaches to management RET fusion-positive NSCLC: Informing on the use of pralsetinib for patients with RET fusion-positive, advanced NSCLC COVID-19 & cancer
Conferences
SABCS 2022 ESMO 2022 2022 ASCO Annual Meeting
About us
Medicine Matters Oncology
EXTENDED SEARCH

17-02-2020 | ASCO GU 2020 | Conference coverage | Video

Researcher comment: The ATLAS trial

Petros Grivas explains why the story of PARP inhibitors in advanced urothelial carcinoma is not quite finished yet despite the negative results of the ATLAS trial of rucaparib in this setting (4:45).

External Content

Click Play to display this content and agree to third party cookies. (>)

Update your current cookie settings.

Read transcript

Related content

12-06-2019 | Urothelial cancer | Video | Article

Researcher comment: Enfortumab vedotin active in advanced urothelial carcinoma

10-10-2019 | Urothelial cancer | Conference coverage | News

Early data look promising for sacituzumab govitecan in metastatic urothelial carcinoma

24-07-2019 | Erdafitinib | Highlight | News

Erdafitinib shows promising efficacy in advanced urothelial carcinoma

23-05-2019 | Urothelial cancer | News

Sustained nivolumab, ipilimumab activity shown in advanced urothelial cancer
  • » This content is intended only for healthcare providers and was made possible by educational funding provided by F. Hoffmann-La Roche Ltd.

ASCO GU 2020 conference hub

ASCO GU 2020 conference hub

Access all the latest news and expert video commentary from the 2020 Genitourinary Cancers Symposium in San Francisco, USA.

Register for conference alerts

Receive the latest content direct to your inbox.

Image Credits